Antibody response durability following three-dose COVID-19 vaccination in people with HIV receiving suppressive ART
View ORCID ProfileHope R. Lapointe, View ORCID ProfileFrancis Mwimanzi, Peter K. Cheung, Yurou Sang, Fatima Yaseen, Sarah Speckmaier, Evan Barad, Nadia Moran-Garcia, Sneha Datwani, Maggie C. Duncan, View ORCID ProfileRebecca Kalikawe, View ORCID ProfileSiobhan Ennis, Landon Young, Bruce Ganase, F. Harrison Omondi, View ORCID ProfileGisele Umviligihozo, View ORCID ProfileWinnie Dong, Junine Toy, Paul Sereda, Laura Burns, View ORCID ProfileCecilia T. Costiniuk, Curtis Cooper, Aslam H. Anis, Victor Leung, View ORCID ProfileDaniel Holmes, View ORCID ProfileMari L. DeMarco, Janet Simons, Malcolm Hedgcock, View ORCID ProfileNatalie Prystajecky, Christopher F. Lowe, View ORCID ProfileMarc G. Romney, Rolando Barrios, Silvia Guillemi, Chanson J. Brumme, View ORCID ProfileJulio S.G. Montaner, Mark Hull, Marianne Harris, View ORCID ProfileMasahiro Niikura, View ORCID ProfileMark A. Brockman, View ORCID ProfileZabrina L. Brumme
doi: https://doi.org/10.1101/2022.11.03.22281912
Hope R. Lapointe
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
Francis Mwimanzi
2Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada
Peter K. Cheung
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
2Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada
Yurou Sang
2Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada
Fatima Yaseen
3Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada
Sarah Speckmaier
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
Evan Barad
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
2Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada
Nadia Moran-Garcia
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
Sneha Datwani
2Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada
Maggie C. Duncan
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
2Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada
Rebecca Kalikawe
2Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada
Siobhan Ennis
2Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada
Landon Young
4Division of Medical Microbiology and Virology, St. Paul’s Hospital, Vancouver, Canada
Bruce Ganase
5AIDS Research Program, St. Paul’s Hospital, Vancouver, Canada
F. Harrison Omondi
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
2Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada
Gisele Umviligihozo
2Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada
Winnie Dong
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
Junine Toy
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
Paul Sereda
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
Laura Burns
6Department of Pathology and Laboratory Medicine, Providence Health Care, Vancouver, Canada
Cecilia T. Costiniuk
7Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre and Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
Curtis Cooper
8Department of Medicine, University of Ottawa, Ottawa, Canada
9Ottawa Hospital Research Institute, Ottawa, Canada
Aslam H. Anis
10School of Population and Public Health, University of British Columbia, Vancouver, Canada
11CIHR Canadian HIV Trials Network, University of British Columbia, Vancouver, Canada
12Centre for Health Evaluation and Outcome Sciences, Vancouver, Canada
Victor Leung
4Division of Medical Microbiology and Virology, St. Paul’s Hospital, Vancouver, Canada
6Department of Pathology and Laboratory Medicine, Providence Health Care, Vancouver, Canada
13Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada
Daniel Holmes
6Department of Pathology and Laboratory Medicine, Providence Health Care, Vancouver, Canada
13Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada
Mari L. DeMarco
6Department of Pathology and Laboratory Medicine, Providence Health Care, Vancouver, Canada
13Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada
Janet Simons
6Department of Pathology and Laboratory Medicine, Providence Health Care, Vancouver, Canada
13Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada
Malcolm Hedgcock
14Spectrum Health, Vancouver, Canada
Natalie Prystajecky
13Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada
15British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, Canada
Christopher F. Lowe
4Division of Medical Microbiology and Virology, St. Paul’s Hospital, Vancouver, Canada
6Department of Pathology and Laboratory Medicine, Providence Health Care, Vancouver, Canada
13Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada
Marc G. Romney
4Division of Medical Microbiology and Virology, St. Paul’s Hospital, Vancouver, Canada
6Department of Pathology and Laboratory Medicine, Providence Health Care, Vancouver, Canada
13Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada
Rolando Barrios
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
10School of Population and Public Health, University of British Columbia, Vancouver, Canada
Silvia Guillemi
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
16Department of Family Practice, Faculty of Medicine, University of British Columbia, Canada
Chanson J. Brumme
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
17Department of Medicine, University of British Columbia, Vancouver, Canada
Julio S.G. Montaner
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
17Department of Medicine, University of British Columbia, Vancouver, Canada
Mark Hull
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
17Department of Medicine, University of British Columbia, Vancouver, Canada
Marianne Harris
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
16Department of Family Practice, Faculty of Medicine, University of British Columbia, Canada
Masahiro Niikura
2Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada
Mark A. Brockman
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
2Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada
3Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada
Zabrina L. Brumme
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
2Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted November 07, 2022.
Antibody response durability following three-dose COVID-19 vaccination in people with HIV receiving suppressive ART
Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, Yurou Sang, Fatima Yaseen, Sarah Speckmaier, Evan Barad, Nadia Moran-Garcia, Sneha Datwani, Maggie C. Duncan, Rebecca Kalikawe, Siobhan Ennis, Landon Young, Bruce Ganase, F. Harrison Omondi, Gisele Umviligihozo, Winnie Dong, Junine Toy, Paul Sereda, Laura Burns, Cecilia T. Costiniuk, Curtis Cooper, Aslam H. Anis, Victor Leung, Daniel Holmes, Mari L. DeMarco, Janet Simons, Malcolm Hedgcock, Natalie Prystajecky, Christopher F. Lowe, Marc G. Romney, Rolando Barrios, Silvia Guillemi, Chanson J. Brumme, Julio S.G. Montaner, Mark Hull, Marianne Harris, Masahiro Niikura, Mark A. Brockman, Zabrina L. Brumme
medRxiv 2022.11.03.22281912; doi: https://doi.org/10.1101/2022.11.03.22281912
Antibody response durability following three-dose COVID-19 vaccination in people with HIV receiving suppressive ART
Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, Yurou Sang, Fatima Yaseen, Sarah Speckmaier, Evan Barad, Nadia Moran-Garcia, Sneha Datwani, Maggie C. Duncan, Rebecca Kalikawe, Siobhan Ennis, Landon Young, Bruce Ganase, F. Harrison Omondi, Gisele Umviligihozo, Winnie Dong, Junine Toy, Paul Sereda, Laura Burns, Cecilia T. Costiniuk, Curtis Cooper, Aslam H. Anis, Victor Leung, Daniel Holmes, Mari L. DeMarco, Janet Simons, Malcolm Hedgcock, Natalie Prystajecky, Christopher F. Lowe, Marc G. Romney, Rolando Barrios, Silvia Guillemi, Chanson J. Brumme, Julio S.G. Montaner, Mark Hull, Marianne Harris, Masahiro Niikura, Mark A. Brockman, Zabrina L. Brumme
medRxiv 2022.11.03.22281912; doi: https://doi.org/10.1101/2022.11.03.22281912
Subject Area
Subject Areas
- Addiction Medicine (425)
- Allergy and Immunology (746)
- Anesthesia (219)
- Cardiovascular Medicine (3240)
- Dermatology (271)
- Emergency Medicine (476)
- Epidemiology (13264)
- Forensic Medicine (19)
- Gastroenterology (893)
- Genetic and Genomic Medicine (5077)
- Geriatric Medicine (472)
- Health Economics (776)
- Health Informatics (3203)
- Health Policy (1130)
- Hematology (423)
- HIV/AIDS (1005)
- Medical Education (468)
- Medical Ethics (126)
- Nephrology (516)
- Neurology (4831)
- Nursing (256)
- Nutrition (717)
- Oncology (2490)
- Ophthalmology (709)
- Orthopedics (279)
- Otolaryngology (338)
- Pain Medicine (321)
- Palliative Medicine (89)
- Pathology (533)
- Pediatrics (1284)
- Primary Care Research (551)
- Public and Global Health (7398)
- Radiology and Imaging (1679)
- Respiratory Medicine (975)
- Rheumatology (474)
- Sports Medicine (417)
- Surgery (536)
- Toxicology (70)
- Transplantation (233)
- Urology (202)